tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Soleno Therapeutics price target lowered to $107 from $121 at Baird
PremiumThe FlySoleno Therapeutics price target lowered to $107 from $121 at Baird
22d ago
Soleno Therapeutics: Sustained U.S. Vykat XR Outperformance and European Upside Support Buy Rating and $100 Target
Premium
Ratings
Soleno Therapeutics: Sustained U.S. Vykat XR Outperformance and European Upside Support Buy Rating and $100 Target
23d ago
Soleno Therapeutics price target lowered to $60 from $75 at Wolfe Research
Premium
The Fly
Soleno Therapeutics price target lowered to $60 from $75 at Wolfe Research
23d ago
Optimistic Outlook for Soleno Therapeutics: Potential Synergy of Vykat in Niche Market Segments
PremiumRatingsOptimistic Outlook for Soleno Therapeutics: Potential Synergy of Vykat in Niche Market Segments
2M ago
CRNX, CYTK, MDGL, SLNO: Top Analyst Outlines Her ‘Top Biotech Ideas for 2026’
Premium
Market News
CRNX, CYTK, MDGL, SLNO: Top Analyst Outlines Her ‘Top Biotech Ideas for 2026’
2M ago
Aardvark Therapeutics initiated with a Strong Buy at Raymond James
Premium
The Fly
Aardvark Therapeutics initiated with a Strong Buy at Raymond James
2M ago
Soleno Therapeutics’ Financial Challenges: Navigating Risks in VYKAT XR Commercialization
PremiumCompany AnnouncementsSoleno Therapeutics’ Financial Challenges: Navigating Risks in VYKAT XR Commercialization
3M ago
Soleno Therapeutics’ Earnings Call Highlights Growth Amid Challenges
Premium
Company Announcements
Soleno Therapeutics’ Earnings Call Highlights Growth Amid Challenges
3M ago
Midday Fly By: Broader market bought on dip after tech selloff
Premium
The Fly
Midday Fly By: Broader market bought on dip after tech selloff
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100